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ABSTRACT
Background
Anaemia is a major cause of morbidity and mortality for children in Africa. The plasma
protein haptoglobin (Hp) binds avidly to free haemoglobin released following malaria-induced
haemolysis. Haptoglobin polymorphisms result in proteins with altered haemoglobin-binding
capacity and different antioxidant, iron-recycling, and immune functions. Previous studies
examined the importance of haptoglobin polymorphism in malaria and iron homeostasis, but it
is unknown whether haptoglobin genotype might be a risk factor for anaemia in children in a
malaria-endemic area.
Methods and Findings
A cohort of 780 rural Gambian children aged 2–6 y was surveyed at the start and end of the
malaria season. Samples were taken to assess haemoglobin (Hb) concentration, iron status
(ferritin, zinc protoporphyrin, transferrin saturation, and soluble transferrin receptor concen-
tration), haptoglobin concentration, a-1-antichymotrypsin (a measure of inflammation), and
malaria parasites on blood film. We extracted DNA and genotyped for haptoglobin, sickle cell,
and glucose-6-phosphate (G6PD) deficiency. Mean Hb levels fell over the malaria season.
Children with the haptoglobin 2-2 genotype (17%) had a greater mean drop in Hb level over
the malaria season (an 8.9 g/l drop; confidence interval [CI] 5.7, 12.1) compared to other
children (a 5.1 g/l drop; CI 3.8, 6.4). In multivariate regression analysis, controlling for baseline
Hb level, age group, village, malaria parasites on blood film, iron status, haptoglobin
concentration, and G6PD deficiency, haptoglobin genotype predicted Hb level at the end of
the malaria season (p ¼ 0.0009, coefficient ¼  4.2). Iron status was not influenced by
haptoglobin genotype.
Conclusions
The finding that haptoglobin 2-2 genotype is a risk factor for anaemia in children in a
malaria-endemic area may reflect the reduced ability of the Hp2-2 polymer to scavenge free
haemoglobin-iron following malaria-induced haemolysis. The magnitude of the effect of
haptoglobin genotype (4 g/l Hb difference, p ¼ 0.0009) was comparable to that of G6PD
deficiency or HbAS (3 g/l difference, p ¼ 0.03; and 2 g/l difference, p ¼ 0.68, respectively).
PLoS Medicine | www.plosmedicine.org May 2006 | Volume 3 | Issue 5 | e172 0652
PLoS MEDICINEIntroduction
Anaemia (haemoglobin [Hb] , 110 g/l) is a serious public
health problem affecting more than half of children less than
5 y of age in malaria-endemic countries of Africa; in a survey
in The Gambia 76% of children were anaemic [1]. Anaemia
has multiple causes, including malaria and micronutrient
deﬁciencies [2]. In sub-Saharan Africa 20% to 40% of
children have undetectable levels of haptoglobin (Hp) due
to haemolysis, and low levels of haptoglobin are strongly
associated with malaria infection [3]. Hp, an acute-phase
plasma protein, is characterised by its strong binding afﬁnity
(.10
10 mol
 1) for free haemoglobin released following
haemolysis. The Hp
1 and Hp
2 alleles are encoded by a single
gene on Chromosome 16; the Hp
2 allele was formed from an
intragenic duplication originating from a nonhomologous
crossing-over of two Hp
1 alleles [4]. Haptoglobin exists in
three common phenotypes: the homodimer Hp1-1, the linear
polymer Hp1-2, and the large circular polymer Hp2-2 [5].
Clear functional differences exist between the phenotypes,
including differences in modulation of oxidant stress,
recycling of haem-iron, and immune function [5]. Haemolytic
stress is likely to accentuate differences between the
phenotypes, as has been found in haptoglobin knock-out
mice compared to wild-type mice [6].
The Hp2-2 polymer has very different biochemical and
biophysical properties compared to Hp1-1 and Hp1-2 [5].
The Hp2-2 protein is present in lower concentrations [7] and
binds less efﬁciently to free haemoglobin; Hp1-1 and Hp1-2
have higher binding afﬁnities [8]. These differences are
reﬂected in vivo by altered oxidant defence and iron
handling. Vitamin C concentrations were signiﬁcantly lower
in the Hp2-2 phenotype (49.9 lmol/l), but did not differ
between Hp1-1 and Hp1-2 individuals (61.5 lmol/l and 63.7
lmol/l respectively) [9]. Furthermore, in Hp2-2 individuals
iron is delocalised into poorly exchangeable storage compart-
ments of the mononuclear phagocytic system; excess mono-
cyte iron was found in the Hp2-2 phenotype (687 lg/g L-
ferritin) compared to the Hp1-1 and Hp1-2 phenotypes (326
lg/g and 366 lg/g L-ferritin, respectively) [10]. However, it is
not known whether Hp2-2 phenotype might be a risk factor
for anaemia in an environment of malaria-induced haemol-
ysis and limited dietary iron availability.
The pathogenesis of malarial anaemia is complex and
includes haemolysis, accelerated erythrophagocytosis, and
cytokine-induced dyserythropoiesis [11,12]; reduced antiox-
idant defence [13,14] and a shift in iron distribution from
functional to storage compartments [15,16] have also been
found. The association between haptoglobin and suscepti-
bility to malaria infection is controversial, and published
reports are conﬂicting. The Hp2-2 phenotype was associated
with protection from severe malaria and placental infection
in a number of case control studies [17–20]. However, a large
study analyzing haptoglobin genotypes and a recent case
control study did not ﬁnd an association [21,22].
We hypothesised that the Hp2-2 phenotype, due to known
functional differences, may be a risk factor for anaemia in
children in an environment of malaria and relative iron
deﬁciency. We thus investigated the possibility that children
homozygous for the Hp
2 allele would have a lower haemo-
globin level after the malaria season. To control for the
multifactorial aetiology of anaemia we measured baseline
haemoglobin levels in the same children prior to the malaria
season, and other factors that might inﬂuence haemoglobin
level. We explored the interaction with plasma iron markers
and compared the impact of haptoglobin with other genetic
polymorphisms that might inﬂuence haemoglobin levels over
the malaria season; namely, HbS and the G6PD A and A 
variants common to sub-Saharan Africa [23].
Methods
Patients and Methods
Ethical permission for the study was granted by the
Gambian Government and Medical Research Council Ethics
Committee, and Gambian National DNA Collection Guide-
lines were followed regarding the handling of genetic
material and information. Parental written informed consent
was obtained for all study participants.
A cohort of 780 children aged from 2 to 6 y was recruited
from ten rural villages in the West Kiang region of The
Gambia at the start of the malaria season, July 2001, with
follow-up to December 2001/January 2002. All children were
eligible except those with serious chronic illness or those
enrolled in another study. Figure 1 provides an overview of
the study population. Ethnic groups were Mandinka (nine
villages, 700 children) and Fulani (one village, 80 children).
Children had anthropometric measurements taken and were
examined by the study clinician. All children received a 3-d
course of mebendazole at the start of the study for possible
hookworm infection. A blood sample was collected for full
blood count, malaria slide, iron status assays, haptoglobin
concentration, a-1-antichymotrypsin (a marker of inﬂamma-
tion), and DNA extraction. Children with a temperature over
37.5 8C had a malaria blood ﬁlm, appropriate clinical
treatment, and a blood sample 2 wk later after recovery from
illness. Children with malaria parasites on blood ﬁlm were
Figure 1. Sample Construction
At the start of the malaria season, 780 children (aged 2–6 y) were
recruited from ten rural Gambian villages, of these, 61 children were lost
to follow-up (of whom four died). At the end of the malaria season, 707
children were surveyed. A total of 671 children had complete
haemoglobin, malaria blood film, and haptoglobin genotype data. After
biochemical assays and further genotyping, 565 children had complete
data for multivariate regression analysis.
DOI: 10.1371/journal.pmed.0030172.g001
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Haptoglobin Genotype and Malaria Anaemiatreated with chloroquine and pyrimethamine-sulfadoxine
(Fansidar) according to Gambian Government guidelines.
This procedure was repeated at the end of the malaria season
for each child.
Malaria incidence is highly seasonal in The Gambia with
the majority of malaria cases occurring between September
and December [24]. Haemoglobin levels in children from the
study area were previously found to be highest in July and
lowest in November [25]. We thus sampled at the start and
end of the malaria season to assess the effect of haptoglobin
genotype on haemoglobin levels in the malaria season
compared to baseline levels. Children were followed across
the malaria season to control for multiple individual factors
that may inﬂuence haemoglobin levels.
Laboratory Procedures and Statistical Analysis
Haemoglobin level was measured by the Medonic CA 530
Oden 16 Parameter System Haemoglobinometer and zinc
protoporphyrin level by the Aviv Biomedical Haematoﬂur-
ometer, within 24 h of collection; daily quality controls were
performed against commercial standards, and duplicate
samples were run. Blood ﬁlms were stained with Giemsa
and examined for malaria parasites according to standard
methods. Frozen plasma samples were analysed at MRC
Human Nutrition Research Laboratories, Cambridge. Hapto-
globin concentration, a marker of recent haemolysis, was
measured by immunoturbidimetry, Tina-quant on the Cobas
Bioanalyser (Roche Systems, Basel, Switzerland). We mea-
sured ferritin concentration by the Imx Ferritin assay, a
Microparticle Enzyme Immunoassay (MEIA), (Abbott Labo-
ratories, Abbott Park, Illinois, United States) and soluble
transferrin receptor (sTfR) concentration by enzyme-linked
immunosorbent assay (ELISA) using a commercially available
kit (R&D Systems, Minneapolis, United States). Serum iron
and unsaturated iron binding capacity (UIBC) were measured
by Ferrozine-based photometry and colorimetry using an
automated analyser (Hitachi 911, Hitachi, Tokyo, Japan).
Transferrin saturation (TS, %) was calculated from plasma
iron and unsaturated iron binding capacity (TS ¼ [plasma
iron/(UIBC þ plasma iron)] 3 100). We also measured a1-
antichymotrypsin, a measure of the inﬂammatory response,
by immunoturbidimetry (Cobas Mira Plus Bioanalyser), to aid
the interpretation of the markers of iron status.
Genotyping (as opposed to the commonly used electro-
phoretic phenotyping) allowed haptoglobin typing of pa-
tients regardless of possible hypohaptoglobinaemia
secondary to subclinical malaria. DNA was extracted from
peripheral blood leucocytes according to standard methods
[26] and quantiﬁed using the PicoGreen assay with measure-
ment of ﬂuorescence by the TECAN SPECTRAﬂuor Plus
ﬂuorimeter. Haptoglobin was genotyped by allele-speciﬁc
PCR, according to a method modiﬁed from Yano et al. [27].
The products were resolved in 1.2% agarose gel, stained with
ethidium bromide, and visualized under UV light. The
oligonucleotide sequences of the haptoglobin primers and
the PCR conditions are detailed in Tables S1 and S2,
respectively. HbS and G6PD deﬁciency (A, A ) polymor-
phisms were genotyped on ampliﬁed DNA (Primer Extension
Pre-ampliﬁcation) [28] by typing single nucleotide poly-
morphisms with Sequenom technology using MALDI-TOF
mass spectrometry. The oligonucleotide sequences of the
primers for HbS and the G6PD A and A  type deﬁciency
polymorphisms are in Table S3.
Statistical Analysis
Analyses were conducted using STATA version 8.0 (Stata,
Timberlake, London, United Kingdom). Pearson’s Chi-square
test assessed associations between haptoglobin genotype and
other genetic polymorphisms, and binomial regression was
used to test for differences in allele frequency between
villages. Normality diagnostics were performed and contin-
uous variables that were not normally distributed were log-
transformed. Weight for height Z-scores were calculated
using Epi Info 2000 software. Prior functional data suggested
the Hp2-2 phenotype had unique properties compared to the
Hp1-2 or Hp1-1 phenotypes [9,10]. This study was designed to
test the hypothesis that these functional differences would
cause in vivo differences in iron and haemoglobin handling
after malaria-induced haemolysis. Thus the primary analysis
compares Hp2-2 with the Hp1-2 and Hp1-1 groups. A
secondary analysis treated each genotype separately.
The effect of haptoglobin and other genotypes on the drop
in haemoglobin was ﬁrst assessed by Student’s t-test. Further
analysis, using stepwise multivariate linear regression, con-
trolled for other variables likely to inﬂuence haemoglobin
level at the end of the malaria season. Here, rather than
normalising haemoglobin values by calculating the drop
during the malaria season, baseline haemoglobin value was
used as an explanatory variable in the model. Age group,
malaria parasites (on blood ﬁlm), village, and baseline
haemoglobin level were ﬁrst included in the model. Other
variables were added manually (in order: sex, markers of iron
status [zinc protoporphyrin, ferritin, soluble transferrin
receptor and transferrin saturation], weight for height Z-
score, a1-antichymotrypsin, haptoglobin concentration,
G6PD deﬁciency, and HbS) and retained if p , 0.1.
Haptoglobin genotype was added last. The validity of the
assumptions of normality and constant variance were con-
ﬁrmed with residual plots.
Results
Characteristics of Study Population
Haptoglobin genotypes were in Hardy-Weinberg equili-
brium. Figure 1 shows numbers of children lost to follow-up
and those with pyrexia who were sampled 2 wk later following
clinical management; haptoglobin genotype distribution did
not differ in either of these groups of children. Four children
died; cause of death was severe malarial anaemia in two (one
of whom had sickle cell disease), cerebral malaria in one, and
the cause was unknown in the fourth. Binomial regression
analysis did not reveal signiﬁcant geographic clustering of the
Hp
2 allele by village, and no association was found between
haptoglobin genotype and either sickle genotype or G6PD
deﬁciency. Table 1 summarises the characteristics of the
sample by haptoglobin genotype.
Univariate Analysis
Overall, mean haemoglobin levels fell across the malaria
season; from 106.9 g/l (95% conﬁdence interval [CI95%]
105.9,108.0) to 101.2 g/l (CI95% 99.9,102.4) by the end of the
malaria season; a mean drop of 5.8 g/l (CI95% 4.5,7.0) (p ¼
0.0001). In primary analysis, children carrying the Hp
2/2
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Haptoglobin Genotype and Malaria Anaemiagenotype had a mean drop in haemoglobin of 8.9 g/l (CI95%
5.7,12.1) compared with 5.1 g/l (CI95% 3.8,6.4) for the other
genotypes (p ¼ 0.02 by Student’s t-test). The drop in
haemoglobin was similar for the Hp
1/1 and Hp
1/2 genotypes
(5.9 g/l and 4.6 g/l respectively). In secondary analysis an
ANOVA for the three genotypes also indicated a greater drop
in mean haemoglobin level in children with the Hp
2/2
genotype (p ¼ 0.045). By comparison, sickle genotype and
G6PD deﬁciency did not signiﬁcantly inﬂuence drop in
haemoglobin level over the malaria season. Drop in haemo-
globin level over the malaria season for haptoglobin, HbAS,
and G6PD A type deﬁciency is shown in Figure 2. Baseline
haemoglobin levels did not differ in the haptoglobin
genotypes, but were lower by the end of the malaria season
in children carrying the Hp
2/2 genotype (p¼0.05 in univariate
analysis, Hp
2/2 versus Hp
1/2 and Hp
1/1 combined). As found
previously [7], children carrying the Hp
2/2 genotype had lower
mean haptoglobin concentrations. We also found an in-
creased number of asymptomatic children with malaria
parasitaemia in the Hp
2/2 group at the end of the malaria
season (p¼0.02 for Hp
2/2 versus Hp
1/1 and Hp
1/2 combined, p¼
0.06 for heterogeneity among the three genotypes).
Multivariate Regression Analysis
Multiple factors inﬂuenced haemoglobin level. A multi-
variate regression analysis was performed with haemoglobin
level at the end of the malaria season as dependent variable.
In this model, baseline haemoglobin level, village, age group,
malaria parasites on blood ﬁlm, iron status, haptoglobin
concentration (a measure of haemolysis in the last 10 d),
G6PD A type deﬁciency, and haptoglobin genotype (p ¼
0.0009, coefﬁcient¼ 4.2) emerged as signiﬁcant predictors of
haemoglobin level at the end of the malaria season (Table 2).
Sex, baseline iron markers (log ZnPP and log soluble
transferrin receptor), weight for height Z-scores, a1-antichy-
motrypsin levels, and sickle genotype were not retained in the
model, as the p-value exceeded 0.1. In a secondary analysis, p
¼ 0.002 for heterogeneity among the three haptoglobin
genotypes. The Hp
1/1 and Hp
1/2 genotypes did not differ (1
g/l difference, p ¼ 0.32). A further multivariate analysis with
change in Hb as the dependent variable found a similar effect
for haptoglobin genotype (p ¼ 0.007, coefﬁcient ¼  4.1). Iron
status (as measured by ferritin, zinc protoporphyrin, trans-
ferrin saturation, and soluble transferrin receptor concen-
tration) strongly inﬂuenced haemoglobin level, but was not
signiﬁcantly altered by haptoglobin genotype.
Discussion
Multiple factors contributed to the complex aetiology of
anaemia in young rural Gambian children; both iron status
and malaria infection emerged as strong predictors of
haemoglobin level. We speculated that haptoglobin, encoded
by a gene that regulates haemoglobin-iron metabolism after
haemolysis, might critically inﬂuence haemoglobin levels in
an environment of malaria-induced haemolytic stress and
Table 1. Characteristics of Study Population by Haptoglobin Genotype
Characteristic Haptoglobin 1-1 Haptoglobin 1-2 Haptoglobin 2-2
Sample size (%) (n ¼ 671)
a 230 (34%) 327 (49%) 114 (17%)
Age (mo) 46.7 (44.9, 48.5) 47.2 (45.7, 48.7) 48.2 (45.6, 50.8)
Male sex (%) 129 (56%) 167 (51%) 65 (57%)
Ethnic group Fulani (%) 22 (9.6%) 31 (9.5%) 13 (11.4%)
Sickle cell (%) Hb AA 192 (83.8%) 285 (88.2%) 97 (85.8%)
Hb AS 36 (15.7%) 35 (10.8%) 16 (14.2%)
Hb SS 1 (0.4%) 3 (0.9%) 0 (0%)
G6PD deficiency (A type) (%) BB 126 (56.8%) 188 (60.8%) 62 (58.5%)
AB 42 (18.9%) 60 (19.5%) 23 (21.7%)
AZ, AA 54 (24.3%) 60 (19.5%) 21 (19.8%)
Weight for height Z-score Baseline  0.90 ( 1.01,  0.79)  0.92 ( 1.01,  0.83)  0.80 ( 0.96,  0.64)
Final  0.56 ( 0.67,  0.46)  0.57 ( 0.66,  0.48)  0.52 ( 0.68,  0.35)
Haemoglobin level (g/l) Baseline 106.9 (105.1, 108.7) 106.8 (105.3, 108.3) 107.3 (104.8, 109.8)
Final 101.0 (98.9, 103.1) 102.2 (100.4, 104.0) 98.4 (95.2, 101.6)*
Drop in haemoglobin level (g/l) 5.9 (3.8, 8.0) 4.6 (2.9, 6.2) 8.9 (5.7, 12.1)*
Ferritin (lg/l) Baseline 40.53 (33.79, 47.27) 36.93 (32.66, 41.20) 39.87 (31.97, 47.77)
Final 38.22 (32.43, 44.01) 31.39 (26.56, 36.21) 38.38 (29.55, 47.21)
Zinc protoporphyrin (lmol/mol haemoglobin) Baseline 100.0 (89.6, 110.4) 108.3 (97.1, 119.4) 101.0 (83.2, 118.6)
Final 134.5 (122.3, 146.7) 135.3 (124.5, 146.1) 139.6 (120.0, 159.2)
Soluble transferrin receptor (nmol/l) Baseline 47.86 (45.30, 50.42) 49.52 (47.12, 51.92) 48.69 (45.47, 51.92)
Final 59.36 (56.01, 62.71) 59.26 (56.58, 61.95) 59.07 (54.56, 63.57)
Transferrin saturation (%) Baseline 14.65 (13.63, 15.66) 15.33 (14.40, 16.27) 14.89 (13.24, 16.55)
Final 13.52 (12.60, 14.45) 13.06 (12.26, 13.86) 14.59 (13.09, 16.10)
a1-Antichymotrypsin (g/l) Baseline 0.46 (0.44, 0.47) 0.46 (0.45, 0.48) 0.46 (0.44, 0.49)
Final 0.40 (0.39, 0.42) 0.40 (0.39, 0.41) 0.40 (0.38, 0.41)
Haptoglobin concentration (lmol/l) Baseline 11.56 (10.66, 12.47) 11.28 (10.11, 12.46) 9.13 (7.28, 10.97)*
Final 7.13 (6.45, 7.81) 6.59 (5.84, 7.34) 4.54 (3.53, 5.55)*
Malaria-positive blood films (%) Baseline 29 (12.6%) 44 (13.5%) 8 (7.02%)
Final 59 (25.7%) 75 (22.9%) 39 (34.2%)*
Values are mean values with (95% CI) except as otherwise noted.
a671 children had complete data for haemoglobin levels, malaria blood films, and haptoglobin genotype. Numbers differ for other genotypes and assays.
*p   0.05 for difference between Hp2-2 versus Hp1-2 and 1-1 combined.
DOI: 10.1371/journal.pmed.0030172.t001
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malaria season, but this effect was concentrated in children
carrying the Hp
2/2 genotype (who had approximately twice
the drop in Hb of children carrying the Hp
1/2 genotype).
Baseline haemoglobin levels were similar by Hp genotype, but
by the end of the malaria season differed signiﬁcantly in the
Hp
2/2 genotype (17% of children) compared to the Hp
1/1 and
Hp
1/2 genotypes (coefﬁcient ¼  4.2, p ¼ 0.0009 in a multi-
variate regression analysis). The effect of Hp
2/2 was greater
than that of previously described genetic variants such as
G6PD A type deﬁciency (3 g/l difference, p ¼ 0.03) and HbAS
(2 g/l difference, p ¼ 0.68). The difference by haptoglobin
genotype was robust to adjustments for other factors
inﬂuencing haemoglobin level and is also supported by our
retrospective analysis of a cross-sectional study of haptoglo-
bin phenotypes conducted in this population in the 1970s
[29]. This found that the Hp2-2 phenotype was associated
with haemoglobin levels of less than 120 g/l (odds ratio¼1.92,
p ¼ 0.028, n ¼ 825). A study from Melanesia has also reported
similar differences in the 0- to 4-y age group in a malaria-
endemic area (albeit based on a small sample size, n¼41) [30].
So how might the Hp
2/2 genotype result in anaemia under
conditions of malaria-induced haemolysis and iron deﬁ-
ciency? We propose three possible explanations for impaired
haematological recovery from malaria infection in the Hp
2/2
genotype. These mechanisms need not be mutually exclusive.
Firstly, impaired iron recycling in the Hp
2/2 genotype due
to delocalisation of iron into poorly exchangeable macro-
phage storage compartments may result in iron-deﬁcient
erythropoiesis. The haemoglobin-scavenging macrophage
receptor CD163 has greater functional afﬁnity for the
Hp2-2-haemoglobin complex compared to the Hp1-1-Hb
complex [31] resulting in signiﬁcantly increased monocyte
iron trapping in Hp2-2 patients [10]. We therefore
hypothesized that prolonged or recurrent episodes of
malaria would result in less efﬁcient recycling of haemoglo-
bin iron and iron-deﬁcient erythropoiesis. However, we did
not ﬁnd an association between haptoglobin genotype and
markers of iron status; it is possible, though, that monocyte
iron levels may have differed between the genotypes. The
association between iron homeostasis and haptoglobin
genotype is controversial; some studies have found that
the Hp
2/2 genotype is associated with iron loading [10,32],
and others have not found an association [33–35]. Further
studies are in progress to assess the associations between
haptoglobin genotype, monocyte-iron levels, and malaria
infection.
Secondly, the Hp
2/2 genotype may inﬂuence haematological
status by failing to quench haemoglobin-iron-mediated
oxidant stress. In vitro work found that the Hp 2-2 protein
was associated with reduced inhibition of oxidation of low-
Table 2. Multivariate Regression Analysis for Haemoglobin Level at the End of the Malaria Season
Factors Influencing Haemoglobin
Level (g/l) at the End of the Malaria Season
Coefficient
(Standard Error)
F-Statistic Significance
(p-Value)
Baseline haemoglobin level (g/l) 0.29 (0.04) 53.01 ,0.00001
Village of origin — 9.67 ,0.00001
Age (grouped by year) — 4.08 0.007
Malaria parasites on blood film Baseline 1.33 (1.5) 0.76 0.38
Final  4.03 (1.2) 11.32 0.0008
Log10 ferritin Baseline 5.19 (1.4) 13.05 0.0003
Final  8.7 (1.4) 39.91 ,0.00001
Log10 zinc protoporphyrin Final  8.4 (2.3) 13.00 0.0003
Log10 soluble transferrin receptor Final  22.83 (3.9) 33.94 ,0.00001
Log10 transferrin saturation Baseline 2.91 (2.4) 1.51 0.22
Final 8.54 (2.4) 12.26 0.0005
Log10 haptoglobin concentration Baseline  3.63 (1.2) 9.36 0.0023
Final 4.33 (1.3) 10.61 0.0012
G6PD deficiency (A type)
a — 3.62 0.027
Haptoglobin genotype  4.17 (1.2) 11.15 0.0009
Sample was n ¼ 565, p   0.00001, F ¼ 32.4, and adjusted R-squared ¼ 0.59.
aChildren with G6PD A  deficiency were too few to include (14 heterozygotes and nine hemizygotes); haptoglobin genotype did not differ between the genotypes (p ¼ 0.81).
DOI: 10.1371/journal.pmed.0030172.t002
Figure 2. Drop in Haemoglobin Level during the Malaria Season
according to HbAS, G6PD Deficiency, and Haptoglobin Genotype
Haemoglobin levels at the start and end of the malaria season are shown
by haptoglobin genotype (Hp
2/2 versus Hp
1/1 and Hp
1/2 combined), HbAS
compared to HbAA and G6PD (A type) deficiency, wild-type, hetero-
zygotes, and homozygotes/hemizygotes. Error bars denote standard
error of the mean.
DOI: 10.1371/journal.pmed.0030172.g002
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Haptoglobin Genotype and Malaria Anaemiadensity lipoprotein (LDL), increased redox active iron and
increased oxidant stress levels compared to the Hp1-1
protein [36,37]. These effects have been conﬁrmed in vivo;
Hp2-2 individuals have reduced vitamin C levels [9,38],
reduced ferroxidase activity if smokers [39], and signiﬁcantly
higher oxLDL/LDL ratios if male [40]. Malarial anaemia is
associated with a reduction in red cell membrane antiox-
idants [13] and increased markers of oxidant stress [41].
Moreover, evidence suggests that oxidant damage to the red
cell membrane leads to accelerated erythrophagocytosis via
aggregation of band 3 proteins and binding of autologous IgG
and complement [42,43].
A third possibility is modulation of inﬂammatory cytokine
balance. Haptoglobin promotes Th1 over Th2 activation in
mice experiments [44] and suppresses monocyte production
of tumour necrosis factor-a, IL-10, and IL-12 in response to
lipopolysaccharide [45]. It is speculated that cross-linking of
the macrophage CD163 receptor by the multimeric Hp2-2-
haemoglobin complex mimics antibody binding and triggers
a signalling cascade resulting in increased secretion of anti-
inﬂammatory cytokines [31,46]. In support of this idea, cross-
linking of the CD163 receptor by haptoglobin-haemoglobin
complexes was found to strongly stimulate IL-10 secretion in
cultured macrophages [47]. Additionally, macrophage iron
loading, as might be seen in the Hp
2/2 genotype, is also
associated with a reduced respiratory burst and decreased
nitric oxide, IFNc, and TNF production [48]. The signiﬁcance
of these possible effects remains to be clearly elucidated but it
is possible that by dampening the inﬂammatory response
Hp2–2 individuals may increase the chronicity of malaria
infections.
The Hp
2 allele is thought to have spread under strong
genetic pressure, and haptoglobin disease associations are
reviewed in Langlois and Delanghe (1996) [5]. The strongest
disease pressure in this age group in rural Africa would be
from malaria. Malaria infects more than 50 million children
each year, and in many parts of Africa the average child has
several malaria infections a year and parasites in the blood
almost continuously [49]. Furthermore, the Hp
2/2 genotype,
present in 17% of children in our study, is also common.
Whether there is an association between haptoglobin poly-
morphisms and susceptibility to malaria infection remains
controversial; studies indicate either a protective or neutral
effect of Hp
2/2 genotype [17–22]. We found an increase in
asymptomatic malaria parasitaemia in the Hp
2/2 genotype at
the end of the malaria season (p ¼ 0.02 for Hp
2/2 versus Hp
1/2
and Hp
1/1 combined). A further possibility is that the Hp
2/2
genotype might be associated with asymptomatic, chronic
parasitaemia that contributes to anaemia, but may also
provide protection against severe malaria.
In summary, our results suggest that the Hp
2/2 genotype is a
risk factor for childhood anaemia in malaria-endemic
countries. The high prevalence of a potentially detrimental
allele might be explained by balancing selection pressures. An
intriguing possibility is that the Hp
2/2 genotype may protect
against life-threatening malaria [18,19] at the expense of
impaired haematological recovery from mild and asympto-
matic malaria. The effect of haptoglobin genotype in other
haemolytic diseases, such as sickle cell, is yet to be elucidated.
Further research is underway to reconﬁrm this ﬁnding and to
investigate the potential mechanisms of anaemia.
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Patient Summary
Background. Anaemia is very common in African children. There are
many different causes of the anaemia, including infections with malaria,
worms, and other parasites. Anaemia is particularly important in children,
as it can affect how well they participate at school, as well as how they
recover from other illnesses.
Why Was This Study Done? There is a protein called haptoglobin
whose job it is to pick up and help remove from the body the
haemoglobin that is released from red cells when they die, either
naturally or after infections such as malaria. This protein exists in two
forms, 1 or 2; the possible combinations of the protein are 1–1, 1–2, or 2–
2. 2–2 is the least efficient at binding to the free haemoglobin. Previous
work has suggested that the haptoglobin type people carry may affect
how they respond to malaria, and whether they become iron deficient.
However, it is not known whether the haptoglobin type of children will
affect their risk of being anaemic in areas where malaria is very common.
What Did the Researchers Do and Find? A total of 780 rural Gambian
children between 2 and 6 years of age were examined at the start and
end of the malaria season. The authors found that average haemoglobin
levels fell over the malaria season, and children who had the haptoglobin
2–2 type had the greatest drop compared to other children. When the
authors looked at a number of other factors, including the children’s age,
haemoglobin at the start of the season, and which village they were
from, the haptoglobin type still predicted whether haemoglobin levels
would fall at the end of the malaria season.
What Do These Findings Mean? These findings suggest that the
haptoglobin type a child has may have be an important influence on
whether that child gets anaemia in areas where malaria is very common.
It is not clear why this haptoglobin type is frequent in this population if it
has an adverse effect on haemoglobin levels; one possibility is that the
2–2 type may protect against life-threatening malaria. Further research
needs to be done to check this finding and to investigate exactly the
potential mechanisms of anaemia.
Where Can I Get More Information Online? The World Health
Organization has a page of information on anaemia:
http://www.who.int/topics/anaemia/en
Medline Plus has a page of links to malaria:
http://www.nlm.nih.gov/medlineplus/malaria.html
and an explanation of what haptoglobin is:
http://www.nlm.nih.gov/medlineplus/ency/article/003634.htm
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